PCM
NVCR icon

Peregrine Capital Management’s NovoCure NVCR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-40,095
Closed -$2.41M 327
2023
Q1
$2.41M Buy
40,095
+7,183
+22% +$432K 0.07% 245
2022
Q4
$2.41M Sell
32,912
-7,918
-19% -$581K 0.08% 240
2022
Q3
$3.1M Sell
40,830
-2,268
-5% -$172K 0.1% 243
2022
Q2
$3M Sell
43,098
-27
-0.1% -$1.88K 0.09% 247
2022
Q1
$3.57M Sell
43,125
-3,139
-7% -$260K 0.08% 251
2021
Q4
$3.47M Buy
46,264
+8,898
+24% +$668K 0.07% 253
2021
Q3
$4.34M Sell
37,366
-7,381
-16% -$857K 0.09% 251
2021
Q2
$9.93M Sell
44,747
-28,133
-39% -$6.24M 0.18% 232
2021
Q1
$9.63M Sell
72,880
-2,917
-4% -$386K 0.18% 235
2020
Q4
$13.1M Sell
75,797
-50,699
-40% -$8.77M 0.25% 192
2020
Q3
$14.1M Sell
126,496
-62,908
-33% -$7M 0.37% 102
2020
Q2
$11.2M Buy
189,404
+38,715
+26% +$2.3M 0.32% 120
2020
Q1
$10.1M Buy
150,689
+554
+0.4% +$37.3K 0.36% 116
2019
Q4
$12.7M Sell
150,135
-1,807
-1% -$152K 0.32% 128
2019
Q3
$11.4M Sell
151,942
-50,675
-25% -$3.79M 0.31% 130
2019
Q2
$12.8M Sell
202,617
-23,088
-10% -$1.46M 0.32% 134
2019
Q1
$10.9M Sell
225,705
-157,716
-41% -$7.6M 0.27% 145
2018
Q4
$12.8M Sell
383,421
-75,138
-16% -$2.52M 0.36% 125
2018
Q3
$24M Sell
458,559
-412,470
-47% -$21.6M 0.57% 69
2018
Q2
$27.3M Sell
871,029
-51,439
-6% -$1.61M 0.68% 45
2018
Q1
$20.1M Buy
922,468
+56,797
+7% +$1.24M 0.49% 73
2017
Q4
$17.5M Buy
865,671
+238,195
+38% +$4.81M 0.41% 95
2017
Q3
$12.5M Sell
627,476
-218,560
-26% -$4.34M 0.3% 132
2017
Q2
$14.6M Sell
846,036
-364,898
-30% -$6.31M 0.36% 105
2017
Q1
$10.1M Buy
1,210,934
+83,448
+7% +$693K 0.26% 157
2016
Q4
$8.85M Buy
1,127,486
+192,178
+21% +$1.51M 0.23% 203
2016
Q3
$7.99M Buy
+935,308
New +$7.99M 0.21% 217